Ann Chang
3M (United States)(US)University of Toronto(CA)
Research Areas
Pharmaceutical Practices and Patient Outcomes, Patient Safety and Medication Errors, Opioid Use Disorder Treatment, Virology and Viral Diseases, Microfluidic and Bio-sensing Technologies
Most-Cited Works
- → Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo(2022)18 cited
- → Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis(2022)4 cited